{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:42:37Z","timestamp":1791852157469,"version":"4.3.4"},"reference-count":87,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Disease Clinics of North America"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.idc.2021.08.002","type":"journal-article","created":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T19:38:06Z","timestamp":1635449886000},"page":"1027-1053","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":110,"title":["Nosocomial Fungal Infections"],"prefix":"10.1016","volume":"35","author":[{"given":"Geehan","family":"Suleyman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George J.","family":"Alangaden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.idc.2021.08.002_bib1","first-page":"85","article-title":"Invasive fungal infections in transplant recipients","volume":"1","author":"Vazquez","year":"2013","journal-title":"Ther Adv Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2021.08.002_bib2","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of Aspergillosis: 2016 update by the Infectious Diseases Society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2021.08.002_bib3","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical practice guideline for the management of candiadiasis; 2016 update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2021.08.002_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/ice.2019.296","article-title":"Antimicrobial-resistant pathogens associated with adult healthcare-associated infections: summary of data reported to the National Healthcare Safety Network, 2015\u20132017","volume":"41","author":"Weiner-Lastinger","year":"2020","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"3","key":"10.1016\/j.idc.2021.08.002_bib5","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/cid\/civ297","article-title":"Review of fungal outbreaks and infection prevention in healthcare settings during construction and renovation","volume":"61","author":"Kanamori","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2021.08.002_bib6","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2147\/TCRM.S40160","article-title":"Epidemiology and risk factors for invasive candidiasis","volume":"10","author":"Yapar","year":"2014","journal-title":"Ther Clin Risk Manag"},{"issue":"Suppl 1","key":"10.1016\/j.idc.2021.08.002_bib7","doi-asserted-by":"crossref","first-page":"S142","DOI":"10.1093\/ofid\/ofy210.374","article-title":"National burden of candidemia, United States","volume":"5","author":"Tsay","year":"2018","journal-title":"Open Forum Infect Dis"},{"issue":"7","key":"10.1016\/j.idc.2021.08.002_bib9","doi-asserted-by":"crossref","first-page":"3950","DOI":"10.1128\/AAC.06258-11","article-title":"Impact of first-line antifungal agents on the outcomes and costs of candidemia","volume":"56","author":"Ha","year":"2012","journal-title":"Antimicrobial Agents Chemother"},{"issue":"1","key":"10.1016\/j.idc.2021.08.002_bib10","doi-asserted-by":"crossref","first-page":"ofw268","DOI":"10.1093\/ofid\/ofw268","article-title":"Trends in hospitalizations related to invasive aspergillosis and mucormycosis in the United States, 2000-2013","volume":"4","author":"Vallabhaneni","year":"2017","journal-title":"Open Forum Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2021.08.002_bib11","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1086\/595846","article-title":"Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry","volume":"48","author":"Neofytos","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2021.08.002_bib12","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1086\/510592","article-title":"Invasive aspergillosis following hemato- poietic cell transplantation: outcomes and prognostic factors associated with mortality","volume":"44","author":"Upton","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.idc.2021.08.002_bib13","first-page":"e162","article-title":"Guidelines for the prevention of intravascular catheter-related infections, 2011. Centers for Disease Control and Prevention","volume":"52","author":"O\u2019Grady","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2021.08.002_bib14","author":"Siegel"},{"issue":"10","key":"10.1016\/j.idc.2021.08.002_bib15","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.bbmt.2009.06.019","article-title":"Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective","volume":"15","author":"Tomblyn","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.idc.2021.08.002_bib16","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/infdis\/168.1.195","article-title":"Nosocomial acquisition of Candida albicans: an epidemiologic study","volume":"168","author":"Vazquez","year":"1993","journal-title":"J\u00a0Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2021.08.002_bib17","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1128\/JCM.36.2.421-426.1998","article-title":"Nosocomial Candida glabrata colonization: an epidemiologic study","volume":"36","author":"Vazquez","year":"1998","journal-title":"J\u00a0Clin Microbiol"},{"issue":"4","key":"10.1016\/j.idc.2021.08.002_bib18","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1128\/CMR.00013-08","article-title":"Candida parapsilosis, an emerging fungal pathogen","volume":"21","author":"Trofa","year":"2008","journal-title":"Clin Microbiol Rev"},{"issue":"15","key":"10.1016\/j.idc.2021.08.002_bib19","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1001\/jama.2020.2717","article-title":"Prevalence and outcomes of infection among patients in intensive care units in 2017","volume":"323","author":"Vincent","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.idc.2021.08.002_bib20","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1086\/591033","article-title":"Secular trends in candidemia-related hospitalization in the United States, 2000\u20132005","volume":"29","author":"Zilberberg","year":"2008","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"7","key":"10.1016\/j.idc.2021.08.002_bib21","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1093\/infdis\/jiaa502","article-title":"Invasive candidiasis species distribution and trends, United States, 2009-2017","volume":"223","author":"Ricotta","year":"2021","journal-title":"J\u00a0Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2021.08.002_bib22","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.diagmicrobio.2012.10.003","article-title":"Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance\u00ae) registry, 2004\u20132008","volume":"74","author":"Pfaller","year":"2012","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2021.08.002_bib23","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.diagmicrobio.2012.06.012","article-title":"The PATH (Prospective Antifungal Therapy) Alliance\u00ae registry and invasive fungal infections: update 2012","volume":"73","author":"Azie","year":"2012","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2021.08.002_bib24","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1128\/JCM.02117-09","article-title":"Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida Species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion","volume":"48","author":"Pfaller","year":"2010","journal-title":"J\u00a0Clin Microbiol"},{"issue":"4","key":"10.1016\/j.idc.2021.08.002_bib25","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s11046-004-1820-x","article-title":"Epidemiology and molecular typing of Candida isolates from burn patients","volume":"158","author":"Gupta","year":"2004","journal-title":"Mycopathologia"},{"issue":"1","key":"10.1016\/j.idc.2021.08.002_bib26","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1053\/jhin.2000.0849","article-title":"Nosocomial Candida albicans acquisition in a geriatric unit: epidemiology and evidence for person-to-person trans mission","volume":"47","author":"Fanello","year":"2001","journal-title":"J\u00a0Hosp Infect"},{"issue":"11","key":"10.1016\/j.idc.2021.08.002_bib27","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1007\/s10096-003-1013-4","article-title":"Nosocomial cluster of Candida guiller- mondii fungemia in surgical patients","volume":"22","author":"Masala","year":"2003","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"11\u201312","key":"10.1016\/j.idc.2021.08.002_bib28","doi-asserted-by":"crossref","first-page":"892","DOI":"10.3109\/00365540903161531","article-title":"Candida rugosa: a distinctive emerging cause of candidaemia. A case report and review of the literature","volume":"41","author":"Minces","year":"2009","journal-title":"Scand J Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2021.08.002_bib29","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1093\/cid\/cix744","article-title":"Approach to the investigation and management of patients with Candida auris, an emerging multidrug-resistant yeast","volume":"66","author":"Tsay","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2021.08.002_bib30","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.15585\/mmwr.mm6544e1","article-title":"Investigation of the first seven reported cases of Candida auris, a globally emerging invasive, multidrug-resistant fungus \u2014 United States, May 2013\u2013August 2016","volume":"65","author":"Vallabhaneni","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.idc.2021.08.002_bib31","doi-asserted-by":"crossref","first-page":"56","DOI":"10.15585\/mmwr.mm7002e3","article-title":"Candida auris outbreak in a COVID-19 specialty care unit \u2014 Florida, July\u2013August 2020","volume":"70","author":"Prestel","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"10.1016\/j.idc.2021.08.002_bib32","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00029-17","article-title":"Candida auris: a review of the literature","volume":"31","author":"Jeffery-Smith","year":"2017","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.idc.2021.08.002_bib33","doi-asserted-by":"crossref","first-page":"6","DOI":"10.15585\/mmwr.mm6901a2","article-title":"Candida auris isolates resistant to three classes of antifungal medications \u2014 New York, 2019","volume":"69","author":"Ostrowsky","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.idc.2021.08.002_bib34","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3389\/fcimb.2020.00370","article-title":"Malassezia spp. Yeasts of emerging concern in fungemia","volume":"10","author":"Rhimi","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"issue":"3","key":"10.1016\/j.idc.2021.08.002_bib35","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1093\/mmy\/myt004","article-title":"Bloodstream infections by Malassezia and Candida species in critical care patients","volume":"52","author":"Iatta","year":"2014","journal-title":"Med Mycol"},{"issue":"4","key":"10.1016\/j.idc.2021.08.002_bib36","doi-asserted-by":"crossref","first-page":"ofv141","DOI":"10.1093\/ofid\/ofv141","article-title":"Epidemiology and outcome of trichosporon fungemia: a review of 185 reported cases from 1975 to 2014","volume":"2","author":"Liao","year":"2015","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2021.08.002_bib37","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1086\/599614","article-title":"Invasive trichosporonosis caused by Trichosporon asahii and other unusual Trichosporon species at a medical center in Taiwan","volume":"49","author":"Ruan","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.idc.2021.08.002_bib38","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1093\/cid\/ciw122","article-title":"Healthcare Outbreaks associated with a water reservoir and infection prevention strategies","volume":"62","author":"Kanamori","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"Suppl 5","key":"10.1016\/j.idc.2021.08.002_bib40","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1469-0691.2009.02982.x","article-title":"Outbreaks of zygomycosis in hospitals","volume":"15","author":"Antoniadou","year":"2009","journal-title":"Clin Microbiol Infect"},{"issue":"9264","key":"10.1016\/j.idc.2021.08.002_bib41","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(00)04423-8","article-title":"Airborne outbreak of nosocomial Scedosporium prolificans infection","volume":"357","author":"Guerrero","year":"2001","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.idc.2021.08.002_bib42","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1439-0507.2008.01642.x","article-title":"Aspergillus flavus: an emerging non-fumigatus Aspergillus species of significance","volume":"52","author":"Krishnan","year":"2009","journal-title":"Mycoses"},{"issue":"4","key":"10.1016\/j.idc.2021.08.002_bib43","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1365-2141.2007.06812.x","article-title":"Risks, diagnosis and outcomes of invasive fungal infec- tions in haematopoietic stem cell transplant recipients","volume":"139","author":"Barnes","year":"2007","journal-title":"Br J Haematol"},{"issue":"Suppl 4","key":"10.1016\/j.idc.2021.08.002_bib44","doi-asserted-by":"crossref","first-page":"S180","DOI":"10.1111\/j.1600-6143.2009.02910.x","article-title":"Invasive aspergillosis in solid organ transplant recipients","volume":"9","author":"Singh","year":"2009","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1016\/j.idc.2021.08.002_bib45","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1086\/518852","article-title":"Invasive aspergillosis in the inten- sive care unit","volume":"45","author":"Meersseman","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.idc.2021.08.002_bib46","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S2213-2600(18)30274-1","article-title":"Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study","volume":"6","author":"Schauwvlieghe","year":"2018","journal-title":"Lancet Respir Med"},{"issue":"4","key":"10.1016\/j.idc.2021.08.002_bib47","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.3201\/eid2704.204895","article-title":"COVID-19-Associated Pulmonary Aspergillosis, March-August 2020","volume":"27","author":"Salmanton-Garc\u00eda","year":"2021","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2021.08.002_bib48","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jhin.2006.02.014","article-title":"Nosocomial aspergillosis in outbreak settings","volume":"63","author":"Vonberg","year":"2006","journal-title":"J\u00a0Hosp Infect"},{"issue":"12","key":"10.1016\/j.idc.2021.08.002_bib49","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1086\/648452","article-title":"Molecular epidemiology of invasive aspergil- losis: lessons learned from an outbreak investigation in an Australian hema- tology unit","volume":"30","author":"Kidd","year":"2009","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"4","key":"10.1016\/j.idc.2021.08.002_bib50","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1128\/JCM.01685-08","article-title":"Sequence-based identification of Aspergillus, Fusarium, and Mucorales species in the clinical mycology labora- tory: where are we and where should we go from here?","volume":"47","author":"Balajee","year":"2009","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.idc.2021.08.002_bib51","doi-asserted-by":"crossref","first-page":"950643","DOI":"10.1155\/2014\/950643","article-title":"Mucormycosis in a renal transplant recipient. case report and comprehensive review of literature","volume":"2014","author":"Hamdi","year":"2014","journal-title":"Int J Nephrol"},{"issue":"5","key":"10.1016\/j.idc.2021.08.002_bib52","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/432579","article-title":"Epidemiology and outcome of zygo- mycosis: a review of 929 reported cases","volume":"41","author":"Roden","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2021.08.002_bib53","doi-asserted-by":"crossref","first-page":"481","DOI":"10.15585\/mmwr.mm6518a5","article-title":"Notes from the field. Probable Mucormycosis among adult solid organ transplant recipients at an acute care hospital \u2014 Pennsylvania, 2014\u20132015","volume":"65","author":"Novosad","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"9","key":"10.1016\/j.idc.2021.08.002_bib54","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1128\/JCM.00908-09","article-title":"Outbreak of intestinal infection due to Rhizopus microsporus","volume":"47","author":"Cheng","year":"2009","journal-title":"J\u00a0Clin Microbiol"},{"issue":"5","key":"10.1016\/j.idc.2021.08.002_bib55","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/INF.0000000000000261","article-title":"Mucormycosis outbreak associated with hospital linens","volume":"33","author":"Duffy","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.idc.2021.08.002_bib56","doi-asserted-by":"crossref","first-page":"e20200013","DOI":"10.1590\/0037-8682-0013-2020","article-title":"Human fusariosis: An emerging infection that is difficult to treat","volume":"53","author":"Batista","year":"2020","journal-title":"Rev Soc Bras Med Trop"},{"issue":"8","key":"10.1016\/j.idc.2021.08.002_bib57","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1001\/jama.296.8.953","article-title":"Multistate outbreak of Fusarium keratitis associated with use of a contact lens solution","volume":"296","author":"Chang","year":"2006","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.idc.2021.08.002_bib58","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1086\/383319","article-title":"Fusarium infection in hematopoietic stem cell transplant recipients","volume":"38","author":"Nucci","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.idc.2021.08.002_bib59","doi-asserted-by":"crossref","first-page":"5109","DOI":"10.1128\/JCM.42.11.5109-5120.2004","volume":"42","author":"O\u2019Donnell","year":"2004","journal-title":"J\u00a0Clin Microbiol"},{"issue":"suppl_1","key":"10.1016\/j.idc.2021.08.002_bib60","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1093\/mmy\/myx113","article-title":"Scedosporium and Lomentospora: an updated overview of underrated opportunists","volume":"56","author":"Ramirez-Garcia","year":"2018","journal-title":"Med Mycol"},{"issue":"9","key":"10.1016\/j.idc.2021.08.002_bib61","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1086\/605324","article-title":"Contaminated product water as the source of Phialemonium curvatum bloodstream infection among patients undergoing hemodialysis","volume":"30","author":"Rao","year":"2009","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"42","key":"10.1016\/j.idc.2021.08.002_bib62","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.15585\/mmwr.mm6442a4","article-title":"Update on multistate outbreak of fungal infections associated with contaminated methylprednisolone injections, 2012\u20132014","volume":"64","author":"McCotter","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"10.1016\/j.idc.2021.08.002_bib63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jhin.2016.01.018","article-title":"Systematic review of outbreaks of Pneumocystis jirovecii pneumonia: evidence that P. jirovecii is a transmissible organism and the implications for healthcare infection control","volume":"93","author":"Yiannakis","year":"2016","journal-title":"J\u00a0Hosp Infect"},{"issue":"1","key":"10.1016\/j.idc.2021.08.002_bib64","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1186\/s12879-019-4002-7","article-title":"The impact of chlorhexidine bathing on hospital-acquired bloodstream infections: a systematic review and meta-analysis","volume":"19","author":"Musuuza","year":"2019","journal-title":"BMC Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2021.08.002_bib65","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13613-015-0073-9","article-title":"Efficacy of chlorhexidine bathing for reducing healthcare associated bloodstream infections: a meta-analysis","volume":"5","author":"Choi","year":"2015","journal-title":"Ann Intensive Care"},{"issue":"6","key":"10.1016\/j.idc.2021.08.002_bib66","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1056\/NEJMoa1113849","article-title":"Effect of daily chlorhexidine bathing on hospital-acquired infection","volume":"368","author":"Climo","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.idc.2021.08.002_bib67","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ijnurstu.2017.01.007","article-title":"Antiseptic barrier cap effective in reducing central line-associated bloodstream infections: a systematic review and meta-analysis","volume":"69","author":"Voor In 't Holt","year":"2017","journal-title":"Int J Nurs Stud"},{"issue":"12","key":"10.1016\/j.idc.2021.08.002_bib68","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1017\/ice.2015.219","article-title":"Use of disinfection cap to reduce central-line-associated bloodstream infection and blood culture contamination among hematology-oncology patients","volume":"36","author":"Kamboj","year":"2015","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.idc.2021.08.002_bib69","series-title":"Guidelines for design and construction of hospital and health care facilities","year":"2006"},{"issue":"5","key":"10.1016\/j.idc.2021.08.002_bib70","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1086\/587189","article-title":"Effect of building construction on Aspergillus concentrations in a hospital","volume":"29","author":"Goebes","year":"2008","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"3","key":"10.1016\/j.idc.2021.08.002_bib71","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jhin.2008.07.010","article-title":"Environmental sampling of particulate matter and fungal spores during demolition of a building on a hospital area","volume":"70","author":"Hansen","year":"2008","journal-title":"J\u00a0Hosp Infect"},{"issue":"4","key":"10.1016\/j.idc.2021.08.002_bib72","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jhin.2007.09.013","article-title":"Prospective survey of indoor fungal contamination in hospital during a period of building construction","volume":"67","author":"Sautour","year":"2007","journal-title":"J\u00a0Hosp Infect"},{"issue":"2","key":"10.1016\/j.idc.2021.08.002_bib73","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jhin.2006.10.013","article-title":"Reduced fungal contamination of the indoor environ- ment with the Plasmair (TM) system (Airinspace)","volume":"65","author":"Sixt","year":"2007","journal-title":"J\u00a0Hosp Infect"},{"issue":"15","key":"10.1016\/j.idc.2021.08.002_bib74","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1056\/NEJMra1315399","article-title":"Invasive candidiasis","volume":"373","author":"Kullberg","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.idc.2021.08.002_bib75","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2217\/fmb.15.111","article-title":"T2MR and T2Candida: novel technology for the rapid diagnosis of candidemia and invasive candidiasis","volume":"11","author":"Pfaller","year":"2016","journal-title":"Future Microbiol"},{"issue":"3","key":"10.1016\/j.idc.2021.08.002_bib76","first-page":"178","article-title":"T2Candida for the diagnosis and management of invasive candida infections","volume":"7","author":"Monday","year":"2021","journal-title":"J\u00a0Fungi (Basel)"},{"issue":"6","key":"10.1016\/j.idc.2021.08.002_bib80","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.idc.2021.08.002_bib81","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1093\/cid\/civ507","article-title":"Aspergillus polymerase chain reaction: systematic review of evidence for clinical use in comparison with antigen testing","volume":"61","author":"White","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2021.08.002_bib82","first-page":"236","article-title":"Non-culture based assays for the detection of fungal pathogens","volume":"28","author":"Ota\u0161evi\u0107","year":"2018","journal-title":"J\u00a0Mycol Med"},{"issue":"4","key":"10.1016\/j.idc.2021.08.002_bib83","first-page":"211","article-title":"COVID-19-Associated Candidiasis (CAC): an underestimated complication in the absence of immunological predispositions?","volume":"6","author":"Arastehfar","year":"2020","journal-title":"J\u00a0Fungi (Basel)"},{"issue":"2","key":"10.1016\/j.idc.2021.08.002_bib84","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/myc.13225","article-title":"Increased incidence of candidemia in a tertiary care hospital with the COVID-19 pandemic","volume":"64","author":"Nucci","year":"2021","journal-title":"Mycoses"},{"key":"10.1016\/j.idc.2021.08.002_bib85","article-title":"Candidemia in COVID-19 patients: incidence and characteristics in a prospective cohort compared to historical non-COVID-19 controls","author":"Mastrangelo","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2021.08.002_bib86","doi-asserted-by":"crossref","DOI":"10.1111\/myc.13258","article-title":"Epidemiology and Mycology of Candidaemia in non-oncological medical intensive care unit patients in a tertiary center in the United States: overall analysis and comparison between non-COVID-19 and COVID-19 cases","author":"Macauley","year":"2021","journal-title":"Mycoses"},{"key":"10.1016\/j.idc.2021.08.002_bib87","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1164\/rccm.202004-1038LE","article-title":"COVID-19 associated pulmonary aspergillosis","volume":"202","author":"van Arkel","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.idc.2021.08.002_bib88","article-title":"Epidemiology of invasive pulmonary aspergillosis among COVID-19 intubated patients: a prospective study","author":"Bartoletti","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2021.08.002_bib89","article-title":"A\u00a0national strategy to diagnose COVID-19 associated invasive fungal disease in the ICU","author":"White","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2021.08.002_bib90","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1164\/rccm.202009-3400OC","article-title":"Occurrence of invasive pulmonary fungal infections in patients with severe COVID-19 admitted to the ICU","volume":"203","author":"Fekkar","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.idc.2021.08.002_bib91","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1016\/S1473-3099(20)30847-1","article-title":"Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM\/ISHAM consensus criteria for research and clinical guidance","volume":"21","author":"Koehler","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.idc.2021.08.002_bib92","article-title":"Invasive fungal disease complicating COVID-19: when it rains it pours","volume":"ciaa1342","author":"Hoenigl","year":"2020","journal-title":"Clin Infect Dis"}],"container-title":["Infectious Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552021000751?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552021000751?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:30:34Z","timestamp":1760196634000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891552021000751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":87,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S0891552021000751"],"URL":"https:\/\/doi.org\/10.1016\/j.idc.2021.08.002","relation":{},"ISSN":["0891-5520"],"issn-type":[{"value":"0891-5520","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nosocomial Fungal Infections","name":"articletitle","label":"Article Title"},{"value":"Infectious Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idc.2021.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}